Ovid Therapeutics Announces $175 Million PIPE Financing

Paul Hastings has advised TD Cowen, Leerink Partners, and Oppenheimer & Co. Cooley LLP has advised Ovid Therapeutics Inc.Ovid Therapeutics Inc., a biopharmaceutical company listed on…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here